Big Pharmas Eyeing on Personalized Medicine Market to Sustain Growth

As blockbusters drugs continue to expire, the prospect of smaller markets and shrinking revenues remains a big challenge for the pharmaceutical companies for the coming decade, says RNCOS in its latest research study. End Quote

(1888PressRelease) March 31, 2011 - As per our new research report, "Personalized Medicine Market Analysis", pharmaceutical companies have realized the potential for the emergence of "niche busters" to replace the projected income loss due to the patent expiry of their blockbuster drugs. Further, rather than developing targeted therapeutics in their labs, most of the major pharmaceutical companies are turning to small biotech firms to fill the pipeline with new personalized medicines that could replace lost revenues. As a result, the venture capital community is looking to capitalize on Big Pharma's interest in biotech.

Our understanding on the industry exemplifies that in the coming years, pharma companies will thrive to claim a relatively large share of a segmented pie rather than focusing on a small share of a real large pie, popularly known as the traditional blockbuster model. In addition, the companies will be focusing on educational efforts that will be targeted to raise awareness of and demand for new personalized therapeutics among the consumers.

Besides, we have done thorough research and prudent analysis of Global Personalized Medicines Market and identified some critical factors acting as a catalyst for the industry's current and future growth outlook. The report reveals that the US, Europe, China, and Japan are the major geographical markets exhibiting healthy growth rates. The US market for personalized medicine is anticipated to grow at a CAGR of around 11% during 2009-2015. Based on some concrete market fundamentals, we anticipate that applications in oncology will witness enhanced investments in coming years during our forecast period and will become one of the most dominating market segments in the global personalized medicines market.

"Personalized Medicine Market Analysis" provides thorough research and rational analysis along with reliable statistics of the Global Personalized Medicines Market. The systematic and thorough research provides an insight into its various segments, including core segment, personalized care segment, and nutrition & wellness segment.

Further, the report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in the coming years. The report also provides an insight into the segment-wise market trends prevailing at regional level to present an overview of developments taking place in these segments across the world.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM305.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

space

Other Related Press Releases